Learn more

ONCOBIX CO LTD

Overview
  • Total Patents
    13
  • GoodIP Patent Rank
    134,058
  • Filing trend
    ⇧ 700.0%
About

ONCOBIX CO LTD has a total of 13 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CELGENE QUANTICEL RESEARCH INC, ABAC THERAPEUTICS S L and RELAY THERAPEUTICS INC.

Patent filings per year

Chart showing ONCOBIX CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Ryu Hyung Chul 10
#2 Rajesh Rengasamy 9
#3 Kim Kyong Cheol 9
#4 Kang Dae Ho 8
#5 Kim Sung-Eun 7
#6 Lee Jae Cheol 7
#7 Kim Jae-Sun 7
#8 Rho Jin Kyung 7
#9 Lee Sunho 6
#10 Lee Sangryul 6

Latest patents

Publication Filing date Title
WO2020256477A1 Pyrimidine derivative inhibiting growth of cancer cell and medicinal use thereof
KR102168179B1 Novel pyrimidine derivative showing growth inhibition of cancer cell and pharmaceutical composition comprising the same
KR20210016103A Novel compound for inducing degradation of alk protein and pharmaceutical composition for using in preventing or treating cancer containing the same as an active ingredient
WO2019112344A1 Novel pyrimidine derivative having effect of inhibiting cancer cell growth and pharmaceutical composition containing same
KR20190067699A Novel pyrimidine derivative showing growth inhibition of cancer cell and pharmaceutical composition comprising the same
KR20190003242A Fused pyrimidine derivative as a mutant Epidermal Growth Factor Receptor kinase inhibitor